|
|
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2 |
| 5KL2TR002490-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002530-05 |
|
NCATS |
2022 |
|
|
Institutional Career Development Core |
| 5KL2TR002534-05 |
|
NCATS |
2022 |
|
|
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform |
| 5U01TR003715-02 |
|
NCATS |
2022 |
|
|
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma |
| 3R01CA235162-04S1 |
|
NCI |
2022 |
|
|
Investigating Microenvironmental Interactions in Leptomeningeal Metastasis |
| 5R01CA245499-03 |
|
NCI |
2022 |
|
|
Alternative Splicing Regulation and Mechanotransduction in Skeletal Muscle |
| 1 U01 TR003715-01 |
HINGTGEN, SHAWN |
NCATS |
2021 |
|
|
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
| 1 R01 CA249988-01A1 |
|
NCI |
2021 |
|
|
Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy |
| 1 R42 CA265316-01 |
|
NCI |
2021 |
|
|
Mechanisms of leukemogenesis in Down syndrome |
| 5 R01 CA101774-20 |
CRISPINO, JOHN D |
NCI |
2021 |